Nutanix, Inc. — Form 10-Q Summary
Reporting period: Fiscal first quarter ended October 31, 2023; comparisons are with the three months ended October 31, 2022. Amounts are in U.S. dollars. Nutanix sells enterprise cloud software and services, primarily through channel and OEM partners, under a subscription-focused model.
Financial performance
| Metric | Q1 FY2024 | Q1 FY2023 | Change |
|---|---|---|---|
| Revenue | $511.1 million | $433.6 million | +17.9% |
| Gross profit / GAAP gross margin | $429.1 million / 84.0% | $351.1 million / 81.0% | Margin +3.0 percentage points |
| Operating expenses | $434.8 million | $431.8 million | +0.7% |
| Operating loss / margin | $(5.7) million / (1.1)% | $(80.7) million / (18.6)% | Improved |
| Net loss / diluted loss per share | $(15.9) million / $(0.07) | $(99.5) million / $(0.44) | Improved |
| Operating cash flow | $145.5 million | $65.5 million | +$80.0 million |
| Free cash flow (non-GAAP) | $132.5 million | $45.8 million | +$86.6 million |
Subscription revenue was $479.5 million, up from $402.9 million; professional services revenue was $22.8 million, versus $22.3 million. Non-GAAP operating income was $79.5 million, compared with $10.2 million, and non-GAAP operating margin was 15.6%, versus 2.4%. These non-GAAP measures exclude specified items, including stock-based compensation; stock-based compensation expense was $84.0 million in the quarter.
Billings were $561.1 million, up from $469.7 million; ACV billings were $287.2 million, versus $231.9 million; ARR was $1.664 billion, versus $1.281 billion. These are company-defined performance measures, not GAAP measures.
Liquidity, debt and capital
- At October 31, 2023, cash and cash equivalents were $612.5 million, short-term investments $958.7 million, and restricted cash $2.2 million. Cash, cash equivalents and short-term investments totaled $1.571 billion.
- Current assets were $1.918 billion and current liabilities $1.100 billion. Deferred revenue totaled $1.645 billion.
- Convertible notes had a net carrying value of $1.239 billion: 2.5% notes due 2026 and 0.25% notes due 2027. The 2026 notes accrue 2.5% interest in kind while held by Bain Capital-affiliated entities; the company expects to settle 2027 note principal in cash.
- The company reported $107.1 million in purchase commitments and up to $53.6 million in guarantees to contract manufacturers. Management stated available cash and investments should cover anticipated needs for at least 12 months.
- A $350 million share repurchase authorization was approved in August 2023. Nutanix repurchased approximately 482,000 shares for $17.5 million during the quarter; $332.5 million remained available.
Material changes and management commentary
- Revenue growth reflected higher software revenue, including renewals, and growth in support subscriptions. Management cited shorter average contract durations as a partial offset: approximately 2.9 years versus 3.0 years a year earlier.
- Gross margin improved as software-only sales represented a higher mix and support revenue grew faster than related personnel costs. Sales and marketing expense was nearly flat in dollars but fell to 46.0% of revenue from 54.5%.
- Operating cash flow and free cash flow improved year over year. Management attributed the operating cash flow increase primarily to the smaller net loss.
- Contracted revenue not yet recognized was approximately $1.8 billion; the company expected to recognize about 55% over the next 12 months. Some contracted, unbilled performance obligations are cancellable.
- Management plans to continue investing in product development and sales and marketing while pursuing go-to-market efficiencies and improved cash flow. It gave no specific financial guidance in the supplied filing text.
Risks, contingencies and unusual items
- A previously identified material weakness in internal control over financial reporting remained unremediated as of October 31, 2023. Management reported that disclosure controls were not effective; remediation measures had been implemented but were still being tested.
- The weakness related to controls over third-party software use and related expense accruals. The company corrected prior-period statements for an immaterial understatement of expenses and accrued liabilities; the correction was made prospectively rather than as a cumulative current-period adjustment.
- A $71.0 million securities class-action settlement reserve was paid out after final court approval in October 2023; the prior-period accrual had been partially offset by insurance recovery. A separate securities class action was dismissed pursuant to a settlement described as not material. A related derivative action had been stayed pending the class-action proceedings.
- Risks discussed include sales-cycle variability, adoption and retention, reliance on partners and OEMs, supply-chain delays, competition, shorter subscription terms, and foreign-exchange exposure. The filing states there were no material changes to previously disclosed risk factors.
- Revenue is concentrated among partners: two partners represented 29% and 15% of quarterly revenue. No end customer accounted for more than 10% of revenue or receivables.
Important facts for investors to verify
- Progress and testing results for remediation of the material weakness, and whether disclosure controls become effective.
- Whether revenue, billings, ACV billings and ARR growth persist, including the effects of contract duration and renewal trends.
- Cash conversion and the sustainability of free cash flow, considering subscription-model timing and share repurchases.
- Convertible-note settlement and dilution exposure, especially the 2026 notes’ PIK accrual and conversion terms.
- Partner concentration, customer retention, sales-team productivity, and any developments in litigation, insurance recovery or purchase commitments.